Why use lisinopril and metoprolol together
Pro Research Analysisby 
Searched over 200M research papers
Combined Use of Lisinopril and Metoprolol in Treating Chronic Congestive Heart Failure
Introduction to Lisinopril and Metoprolol
Lisinopril and metoprolol are commonly prescribed medications for managing cardiovascular conditions, particularly chronic congestive heart failure (CHF) and hypertension. Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor, while metoprolol is a beta-blocker. Both drugs have distinct mechanisms of action that complement each other when used together.
Improved Cardiac Function in CHF
Studies have shown that the combination of lisinopril and metoprolol significantly improves cardiac function in patients with chronic congestive heart failure. One study involving 108 patients demonstrated that the combination therapy led to a significant decrease in left ventricular end-diastolic diameter (LVEDD) and increases in left ventricular ejection fraction (LVEF) and cardiac output (CO) compared to monotherapy. Another study with 96 patients found similar improvements in cardiac function, including reductions in heart rate, systolic blood pressure (SBP), and diastolic blood pressure (DBP), as well as an increase in LVEF.
Enhanced Arterial Distensibility
Lisinopril has been shown to improve arterial distensibility, which is a measure of the elasticity of the arterial walls. In a study of 40 patients with essential hypertension, lisinopril significantly increased the percent change in diameter and distensibility of the left common carotid artery, whereas metoprolol did not show such effects. This suggests that lisinopril may offer additional vascular benefits beyond blood pressure reduction.
Blood Pressure Management
Both lisinopril and metoprolol are effective in lowering blood pressure, but they do so through different mechanisms. Lisinopril reduces blood pressure by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. Metoprolol, on the other hand, reduces heart rate and the force of contraction, thereby lowering blood pressure. Studies have shown that both drugs are effective in reducing diastolic and systolic blood pressure, with lisinopril showing a slightly greater reduction in systolic blood pressure.
Quality of Life and Tolerability
The combination of lisinopril and metoprolol is generally well-tolerated by patients. In a study comparing the two drugs, fewer adverse events were reported with lisinopril compared to metoprolol, and patients reported better quality of life on lisinopril in terms of emotional, cognitive, and social functioning. This makes the combination therapy not only effective but also more acceptable to patients.
Conclusion
The combined use of lisinopril and metoprolol offers significant benefits in the treatment of chronic congestive heart failure and hypertension. The complementary mechanisms of action of these drugs lead to improved cardiac function, enhanced arterial distensibility, effective blood pressure management, and better quality of life for patients. Therefore, this combination therapy is a valuable option in clinical practice for managing these cardiovascular conditions.
Sources and full results
Most relevant research papers on this topic